Synergistic Effects of Injectable Platelet-Rich Fibrin and Bioactive Peptides in Dermal Regeneration

Strategic Insights -

Researchers at the University of Sao Paulo have made significant findings in the field of dermal regeneration, focusing on the synergistic effects of injectable platelet-rich fibrin and bioactive peptides. This study examines the potential of combining autologous platelet concentrates with bioactive peptides for enhancing dermal fibroblast viability and extracellular matrix gene expression. The findings demonstrate increased cell viability and upregulated ECM-related genes when fibrin is combined with certain peptides, suggesting promising regenerative properties.

Key Takeaways:

  • The study highlights the potential of combining autologous platelet concentrates with bioactive peptides for dermal regeneration.
  • The synergistic effects of injectable platelet-rich fibrin and bioactive peptides were observed, particularly when combined with GEKG, leading to increased cell viability and upregulated ECM-related genes.
  • The study demonstrated that combining fibrin with Matrixyl or GEKG showed stronger effects than individual treatments, indicating synergistic effects.
  • The research focused on dermal fibroblast viability, proliferation, and ECM-related gene expression, providing insights into the clinical potential of combining autologous platelet concentrates with bioactive peptides.
  • The study made use of a combination of assays, including MTT, crystal violet, RealTime-Glo, and RT-qPCR, to assess cell viability and gene expression.
  • The findings of the study highlight the potential applications of combining fibrin with bioactive peptides for dermal regeneration, with further preclinical and clinical studies warranted.

Statistics:

  • Six conditions were examined in the study: control, i-PRF alone, Matrixyl alone, GEKG alone, i-PRF + Matrixyl, and i-PRF + GEKG.
  • The study showed that the combinations, especially i-PRF + GEKG, led to increased cell viability and upregulated ECM-related genes at 72 hours.
  • The RealTime-Glo assay was used to assess cell viability, with the combination of i-PRF + GEKG showing the strongest effects.
  • The study used RT-qPCR to measure gene expression of *COL1A1*, *FN1*, and *HAS1*, with the combination of i-PRF + GEKG showing the greatest upregulation.

Sources:

  • Synergistic Effects of Injectable Platelet-Rich Fibrin and Bioactive Peptides on Dermal Fibroblast Viability and Extracellular Matrix Gene Expression: An In Vitro Study. Molecules, 2025, 30(16), 3415.
  • Ana Giulia Lenci Paccola, Thomas Marcelino Couto dos Santos, Maria Clara Minelo, Thais Francini Garbieri, Mariana Liessa Rovis Sanches, Thiago Jose Dionisio, Rodrigo Cardoso de Oliveira, Carlos Ferreira Santos, Marilia Afonso Rabelo Buzalaf. University of Sao Paulo, Bauru School of Dentistry, Bauru 17012-901, SP, Brazil.